$QURE had huge Huntington’s trial results and ran to $70, then got cut to $9 after FDA drama with no clear explanation. Now it’s trading below its cash on hand, which feels hard to ignore.

It’s clearly deep speculative. If regulators keep stalling, it stays crushed. If things shift, it could re-rate fast. Is this reckless… or one of those rare asymmetric setups?